Cytek Biosciences CTKB
NASDAQ CTKB
$4.66 -0.04 (-0.85%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cytek Biosciences (CTKB) Other Non-Current Liabilities (2020 - 2026)

Cytek Biosciences' (CTKB) quarterly Other Non-Current Liabilities came in at $2.4 million in Q1 2026, down 72.81% YoY from $8.8 million in Q1 2025, and up 3.94% on a QoQ basis from $2.3 million in Q4 2025.

Cytek Biosciences (CTKB) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Cytek Biosciences (CTKB) has 7 years of Other Non-Current Liabilities data on file, last reported at $2.4 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 72.81% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 72.81% YoY) and the FY2025 annual result came in at $2.3 million, down 2.41% from the prior year.
  • Other Non-Current Liabilities improved to $2.4 million in Q1 2026, from $2.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $16.9 million in Q2 2024 to a low of $1.1 million in Q1 2022.
  • A 5-year average of $5.3 million and a median of $2.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The widest YoY moves for Other Non-Current Liabilities: up 1116.7% in 2023, down 84.89% in 2023.
  • Tracing CTKB's Other Non-Current Liabilities over 5 years: stood at $1.6 million in 2022, then jumped by 53.18% to $2.4 million in 2023, then fell by 2.76% to $2.4 million in 2024, then retreated by 2.41% to $2.3 million in 2025, then rose by 3.94% to $2.4 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $2.4 million (Q1 2026), $2.3 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Cytek Biosciences 602.64 Mn 528.79 Mn 28.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.37 Mn
Mar 31, 2026 2.40 Mn
Dec 31, 2025 2.31 Mn
Sep 30, 2025 2.52 Mn
Jun 30, 2025 8.48 Mn
Mar 31, 2025 8.82 Mn
Dec 31, 2024 2.36 Mn
Sep 30, 2024 2.12 Mn
Jun 30, 2024 16.91 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 2.29 Mn
Jun 30, 2023 16.46 Mn
Mar 31, 2023 1.87 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 15.12 Mn
Jun 30, 2022 1.35 Mn
Mar 31, 2022 1.12 Mn
Dec 31, 2021 1.20 Mn
Sep 30, 2021 12.63 Mn